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ABSTRACT

Author: Kim, Mi Ran. MS
Institution: Purdue University
Degree Received: December 2017
Title: Revealing the Role of TET2 in Stem Cell Fate Decision Using Genetically
Modified Mouse Model
Major Professor: Dr. Chun-Ju (Alice) Chang
Epigenetic control plays a key role in regulation of stem cell fate and tumorigenesis. My
research project is focused on determining the physiological and pathological roles of a
critical epigenetic regulator, TET2, in regulation of mammary stem cell fate and
mammary gland development using a mouse model with mammary specific deletion of
the Tet2 gene. Our data show that knock-out of Tet2 in mouse mammary gland leads to
disrupted mammary epithelial morphology and aberrant mammary stem cell (MaSC) fate
determination, contributing to an expansion of the MaSC population and development of
mammary lesions. Since aberrant MaSC fate is often linked to tumorigenesis, our studies
will not only reveal novel mechanisms by which the MaSC fate is regulated, but also
provide new strategies used for breast cancer treatment.
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CHAPTER 1.

1.1

INTRODUCTION

Motivation

The mammary gland is a remarkably dynamic organ which undergoes developmental
and morphological changes after birth and through puberty, pregnancy, lactation and
involution. The mammary gland epithelium is a ductal system composed of two epithelial
cells: the luminal epithelial cells lining mammary ducts and the basal/myoepithelial cells
surrounding the luminal cells by separating mammary epithelium from extracellular
matrix. Mammary stem cells (MaSCs) can self-renew and produce the multi-potent
progenitors which further differentiate into distinct cell lineages to generate the
functional mammary epithelium. The luminal progenitor cells can differentiate to the
ductal and alveolar cells, and basal/myoepithelial progenitor cells give rise to the
myoepithelial cells during mammary gland development (1)(2). The significant
expansion of the mammary epithelium during puberty and pregnancy particularly reflects
the regenerative capability of the MaSCs/progenitor cells. Epigenetic mechanisms,
including histone modification, DNA methylation, chromatin remodeling, and noncoding RNAs, play important roles in regulation of the stem cell fate (self-renewal vs.
differentiation) (3)(4). It has been shown that many epigenetic regulators are dysregulated
in breast cancer stem cells (BCSCs), a subset of the cancer cell population with acquired
self-renewing properties (stemness) associated with normal stem cells, account for cancer
initiation, progression, metastasis, and recurrence (5)(6)(7). Therefore, determining
critical epigenetic regulators that govern the stem cell/CSC fate will not only provide
profound understanding of breast tumorigenesis, but also reveal effective therapeutic
strategies for preventing breast cancer development.
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1.2

Background

In our recent study, we found that epigenetic regulators, methylcytosine dioxygenase,
Ten Eleven Translocation 2 (TET2), can govern the stem cell fate and regulate the breast
CSC-like population (7). TET family is a core enzyme for DNA demethylation by
converting 5-methylcytosine (5mC) to 5-hydormethylcytosine (5hmC). There are three
mammalian TET proteins, TET1, TET2, and TET3. Tet1/2/3 knock-out murine embryo
shows impaired neuroectodermal and mesodermal development with disrupted cell fate
decision of the progenitor cells during early embryogenesis (8). Tet1/2/3 deficient mouse
embryonic stem cells also develop poorly differentiated embryonic bodies with
hypermethylation of the developmental genes during differentiation (9). Particularly,
TET2 is a main regulator of hematopoietic stem cell homeostasis and is critical for
mediating mast cell differentiation (10); loss of TET2 expression is associated with
hematopoietic malignancy (11)(12). Compared with the normal breast tissues, deficient
TET2 expression is significantly correlated with invasive ductal carcinoma with low
5hmC content (13). Furthermore, recent studies have revealed that TET2 promotes the
expression of microRNA-200c (miR-200c), the most down-regulated microRNA in the
MaSC/CSC population compared with the non-stem cell population; TET2-activated
miR-200c in turn inhibits invasiveness and metastasis of breast cancer cells
(7)(14)(15)(16). Based on these studies, I hypothesize that TET2 plays an important role
in controlling MaSC fate determination to maintain epithelial homeostasis and loss of
TET2 will potentially contribute to breast cancer development.
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1.3

Thesis goal and approach

To understand the role of TET2 in mammary gland development, we have generated
mammary specific Tet2 knock-out mice and observed the morphological difference
between knock-out mice and wild type mice. Knock-out mice were generated by sitespecific recombinase technology, Cre-Lox recombination. Bacteriophage P1 Cre
recombinase recognizes 34 base pair repeats called LoxP and catalyzes site-specific DNA
recombination between two LoxP site. This DNA recombination allows the DNA
modifications, such as insertion, deletion, translocation and inversion at the specific DNA
sites. Also, it can be targeted in specific cell types by using cell type-specific promoters
to drive the expression of the Cre recombinase. For example, MMTV promoter has been
routinely used to express Cre recombinase specifically in the mammary gland epithelial
cells (Figure 1 A, B). Therefore, we bred Tet2fl/fl mice (the Jackson lab) with MMTV-Cre
transgenic mice (the Jackson lab) to knock out Tet2 specifically in the mammary gland.
Then we observed the influence of Tet2 ablation on whole mammary gland and
mammary epithelial cells using whole mount staining and immunofluorescence staining
with specific lineage markers: luminal cells (CK8, MUC1) and basal/myoepithelial cells
(CK14, SMA). Western blot analysis was used to determine expression of luminal cell
markers and the proteins involved in luminal cell differentiation.
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Figure 1. Generation of conditional knock-out mice using Cre-Lox recombination
A) A schematic model of Cre function. B) Cre/Lox mouse breeding strategy to generate
tissue-specific gene knock-out mice.
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CHAPTER 2.

2.1
2.1.1

ESTABLISH AND CHARACTERIZE MAMMARY
SPECIFIC TET2-KO MOUSE MODEL

Material and Method
Generation of conditional Knock-out mouse

The conditional Tet2fl/fl mice line (Tet2tm1.1Iaai, 017375), in which possess loxP site
flanking axon 3 in Tet2 gene (17), and MMTV-Cre transgenic mice line [Tg(MMTVcre)4Mam/J, 003553], which expresses Cre recombinase under the control of mouse
mammary tumor virus (MMTV) long terminal repeat (LTR) promoter, were purchased
from the Jackson Laboratory. Tet2fl/fl mice were bred with MMTV-Cre mice and
mammary gland specific Tet2 knock-out mice line: Tet2fl/fl MMTV-Cre+, Tet2fl/w MMTVCre+, Tet2w/w MMTV-Cre+ mice were generated. 7 weeks old, 18.5 days of pregnancy
and 10 days of lactation mice were sacrificed and intact mammary glands were collected
for further examination. All animal experiments were conducted with approval of the
Purdue Animal Care and Use Committee.
2.1.2

Antibodies

The following antibodies were used for western bolt and immunofluorescent stain: antiTET2 (Active Motif, 61389, 1:1000), anti β-casein (Santa cruz, SC-30042, 1:1000), antiER-α (Abcam, E115, 1:1000), Gata3 (Invitrogen, PA5-20892, 1:1000), CK8 (Abcam,
Ab59400, 1:250), CK14 (Abcam, ab7800, 1:250), MUC1 (Abcam, ab45167, 1:250), αSMA (Sigma Aldrich, A5228, 1:500), Lineage (BD Bioscience, 561317), CD24 (BD
Bioscience, 561777), CD29 (BD Bioscience, 561796) and CD61 (BD Bioscience,
561910).
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2.1,3

Whole mount staining

Entire inguinal mammary gland was removed and directly spread on the glass slides.
The tissue fixed in the Carnoy’s solution (mixture of ethanol, chloroform and glacial
acetic acid; 6:3:1 ratio) for 4 hours at room temperature. Then tissue was gradually
hydrated and stained in carmine alum (Stemcell technologies, 07070) stain overnight at
room temperature. Whole mount was dehydrated in series of ethanol, 50%, 70%, 95%
and 100% for 5min each, cleared in Xylene overnight and kept in methyl salicylate until
taking images. Images were taken by using SteREO Discovery.V12 microscope.
2.1.4

Mammary gland histology

Inguinal mammary gland was fixed in 10% buffered formalin and processed in
histology research laboratory at Purdue. Hematoxylin and eosin stained slides were
provided from histology research laboratory and formalin fixed paraffin embedded
mammary gland sections stained with Trichrome stain kit (ScyTek, TRM-1-IFU)
according to manufacturer’s protocol.
2.1.5

Immunofluorescence staining

The fresh mouse mammary gland was sliced and fixed in 4% paraformaldehyde for one
hour. The tissue slices were incubated with primary antibodies in PBS containing 0.5%
Triton X-100 and 5% BSA overnight at 4°C. The specimens were washed with PBS with
0.1% tween 20 three times and incubated with a fluorochrome-conjugated second
antibodies: Rhodamine Red – conjugated goat anti rabbit IgG and FITC – conjugated
goat anti mouse IgG (Jackson immunoresearch, 1:400), overnight at 4°C. After washing,
the samples were incubated with Hoechst (Life technology, H3570, 1:1000) 10min at
room temperature. Tissue samples placed on the glass slide and mounted with mounting
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solution. After coverslipping, images were taken by Olympus FV10i-LIV Laser Scanning
Microscope.
2.1.6

Flow Cytometry

Mammary glands were collected from 7 week virgin mice in each mouse lines (n=5) and
single cell suspension was generated using EpiCult™-B Mouse Medium Kit (Stemcell,
5610) according to manufacturer’s instruction. Briefly, tissue was dissociated in
EpiCult™-B Medium/Collagenase/Hyaluronidase/FBS/gentamicin solution for 2 hours.
Trypsin-EDTA was added to partially dissociated tissue and live mammary cells were
collected after centrifugation. Dipase and DNase 1 solution was used for further
dissociation and then single cells were collected. Cells were labelled with Lineage
marker, CD24, CD29 and CD61 and used for flow cytometry analysis.

2.2
2.2.1

Results
Generation of conditional Tet2 knock-out mice

We used Cre-Lox recombination to create conditional knock-out mice. To genetically
delete Tet2 in mammary gland, we bred the Tet2fl/fl mouse line which has two insertion of
LoxP sites flanking exon 3 of Tet2 gene (Figure 2A) (17), with the MMTV-Cre
transgenic mice line. Three resulting genotypes, Tet2 knock-out (TET-/-: Tet2fl/fl MMTVCre+), Tet2 HET (TET+/-: Tet2fl/w MMTV-Cre+), and Tet2 wild (TET+/+: Tet2w/w MMTVCre+), were verified by PCR (Figur 2B) and TET2 protein expression (Figure 2C).

8
A)

B)

....

WT HET KO
LoxP
WT
Positive control
MMTVCre

C)
WT
#1 #2

HET
#1 #2

KO
#1 #2
TET2
β-actin

Figure 2. Generation of mammary-specific Tet2 knock-out mice.
A) Schematic illustration of the targeted Tet2 allele. Exon 3 is targeted and flanked by
LoxP sites. B) Verification of MMTV-Cre mediated deletion using genomic PCR. Floxed
and wild type Tet2 alleles are shown. C) Western blot analysis shows relative TET2
expression levels in the mouse mammary gland (courtesy of Meng-Ju Wu).
2.2.2

Morphologic changes of Tet2 knock-out mammary gland.

To elucidated morphologic changes of mammary gland in wild type and Tet2 knock-out
mice, we performed whole mount stain, H&E, and trichrome stain at the age of 7 week.
Loss of Tet2 leads to increased ductal length, extensive side branching, enlarged terminal
end buds, and substantial fibrosis near the ductal area (Figure 3).
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Figure 3. Morphology and histology analysis of MMTV-Cre-Tet2 knockout mammary
glands.
Representative images of mammary gland stained with Carmine (whole mount), H&E,
and trichrome. Mammary gland was collected from the number 4 inguinal mammary
gland from wild-type (Tet2+/+): MMTV-Cre; Tet2+/+ (upper panels), HET (Tet2+/-):
MMTV-Cre; Tet2loxP/+ (middle panels) and KO (Tet2-/-): MMTV-Cre; Tet2loxP/loxP at 7
week old. In whole mounts, low-power (left column) and high-power (right column) are
presented. Histological sections collected from WT (upper), HET (middle) and KO
(bottom) 7-week virgin mice by hematoxylin and eosin staining and Masson’s Trichrome
are illustrated (light blue region indicates collagen enriched fibrosis).

2.2.3

TET2 is required for mammary development during pregnancy and lactation.

We examined the morphology of mammary glands from 18.5 days of pregnant mice and
10 days lactating mice from wild-type (Tet2+/+), HET (MMTV-Tet2+/-) and KO (MMTVTet2-/-) to evaluate the development of mammary gland during pregnancy and postpartum
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lactation. Late pregnancy and lactation of Tet2 knock-out mice show severe defects in
lobuloalveolar development with decreased milk production (Figure 4A, 4B).
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Figure 4. Morphology and histology analysis of MMTV-Cre-Tet2 knockout mammary
glands during pregnancy and lactation.
A) Mammary glands at 18.5 day of pregnancy. Carmine-stained whole mounts of
mammary glands (left panels) and hematoxylin and eosin staining (H&E) at low (middle)
and high (right) magnifications. Dotted area represents terminal alveoli. Arrow shows milk
deposition in the secretory alveoli. B) Mammary glands at 10 days of lactation. H&E low
power scale bar=200 μm; H&E high power scale bar=50 μm.
2.2.4

Knock-out of Tet 2 increases the murine mammary stem cell population

To elucidate the mammary cell subsets regulated by TET2 expression, we used flow
cytometry analysis of cells isolated from 7-week virgin mice labelled with CD24, CD29
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and CD61. The mammary subsets corresponding to the mammary stem cells (MaSC,
CD24+CD29hi CD61+), luminal progenitor cell (LumP, CD24+CD29loCD61+), mature
luminal cells (LumM, CD24+CD29loCD61-), and stroma cells (CD24-CD29lo).
Significantly increased mammary stem cell population was observed in the Tet2 KO
mouse along with reduced mature luminal cell subset (Figure 5A, Figure 5B).
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Figure 5. Knock-out of Tet 2 leads to an expansion of mammary stem cells.
Mammary cells were isolated and analyzed by flow cytometry for (A-B) LinCD24+CD29hiCD61hi (MaSC), Lin-CD24+CD29loCD61hi (LumP) and LinCD24+CD29loCD61lo (LumM) populations from the mammary glands of Tet2-WT,
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MMTV-Tet2-HET and MMTV-Tet2-KO 7-week-old virgin mice. Independent
experiments were repeated with five animals per genotype.
2.2.5

Knock-out of Tet 2 leads to dysregulated basal/ myoepithelial and luminal cell
commitment

We used cytokeratin 8 (CK8) and mucin (MUC) for detecting luminal lineage of
mammary cells; cytokeratin 14 (CK14) and smooth muscle actin (SMA) for
basal/myoepithelial lineage to determine the impact of Tet2 ablation on cell lineage
commitment in the mouse mammary gland. Loss of TET2 expression induces enlarged
alveoli with irregular shape (Figure 6A) and directs the cell fate to favor
basal/myoepithelial lineage differentiation (Figure 6A, 6B).
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Figure 6. Whole mount double immunofluorescence analysis of luminal and basal cell
marker expression in mammary gland of 7-week-old virgin mice from wild-type (Tet2+/+)
and KO (MMTV-Tet2-/-)
(A) Mammary gland stained for Hoechst 33342, CK8 (Red) and CK14 (Green). Arrows
show the aberrant morphology of terminal alveoli. (B) stained for Hoechst 33342,
MUC1 (Red) and SMA (Green).
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2.2.6

Tet2 knock-out leads to defective luminal cell differentiation

Next, we questioned whether TET2 plays a role in luminal cell differentiation. We used
western blot analysis to measure the expression levels of luminal cell markers, such as βcasein and estrogen receptor 𝛂 (ER-𝛂), and the gene which play an important role in
regulating luminal cell differentiation, such as Gata3. We found that loss of TET2
significantly decreased expression of β-casein, ER-𝛂, and GATA3 (Figure 6). This data
demonstrates that TET2 expression may be required for luminal cell differentiation/
lineage commitment by regulating GATA3 expression.
WT
HET
#1 #2 #1 #2

KO
#1 #2

13-casein
ER-a

Gata3
13-actin

Figure 7 Knock-out of Tet2 impairs protein expression involved in luminal cell
differentiation.
Western blot analysis of the expression of β-casein, estrogen receptor 𝛂 (ER-𝛂), and
GATA3 in mammary gland from wild-type (Tet2+/+), HET (MMTV-Tet2+/-) and KO
(MMTV-Tet2-/-) at 7-week old mice (courtesy of Meng-Ju Wu).
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CHAPTER 3.

SUMMARY AND FUTURE DIRECTION

In this study, we have successfully established and validated mammary-specific Tet2
knock-out mice. The data generated from the mammary tissues suggest that TET2 is
required for mammary gland development throughout puberty, pregnancy, and lactating
period. Furthermore, loss of TET2 leads to disrupted epithelial morphology and
dysregulated MaSC differentiation that expands MaSC/basal cell pool. The next step is to
investigate the mechanisms underlying the TET2-mediated MaSC differentiation, which
will likely provide new strategies for breast cancer treatment.
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